XPect-PD Syrup Strawberry is a combination pharmaceutical formulation containing Terbutaline sulfate (1.25 mg) and Ambroxol hydrochloride (15 mg) per 5 ml dose, indicated for the management of respiratory conditions characterized by bronchospasm and excessive mucus production. Terbutaline, a selective beta-2 adrenergic receptor agonist, acts as a bronchodilator by relaxing bronchial smooth muscles, thereby facilitating improved airflow and alleviating symptoms such as wheezing and shortness of breath. Ambroxol serves as a mucolytic agent, enhancing the clearance of mucus by breaking down its structure, reducing viscosity, and promoting expectoration. This synergistic action makes XPect-PD Syrup effective in treating obstructive airway diseases including asthma, chronic bronchitis, and other respiratory tract infections where mucus retention and bronchoconstriction are present. The strawberry-flavored syrup formulation ensures better palatability and compliance, especially in pediatric patients. XPect-PD Syrup should be used under medical supervision, with dosage adjusted according to patient age, severity of symptoms, and clinical response. Caution is advised in patients with cardiovascular disorders, hyperthyroidism, or hypersensitivity to any component. Common adverse effects may include tremors, palpitations, and gastrointestinal discomfort. This medication is contraindicated in patients with known hypersensitivity to Terbutaline or Ambroxol and should be stored at room temperature away from direct sunlight.